View in EDS HTML Full Text PDF Full Text

Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy.

Saved in:
Bibliographic Details
Title: Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy.
Authors: Antolí A; Department of Internal Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Rocamora-Blanch G; Department of Internal Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Framil M; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Department of Immunology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Mas-Bosch V; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Department of Immunology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Navarro S; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Department of Immunology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Bermudez C; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Martinez-Yelamos S; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Department of Neurology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain., Dopico E; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Deparment of Microbiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Calatayud L; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Deparment of Microbiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain., Garcia-Muñoz N; Blood Bank Department - Banc de Sang i Teixits (BST), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Hernández-Benítez LH; Blood Bank Department - Banc de Sang i Teixits (BST), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Riera-Mestre A; Department of Internal Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain., Bas J; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Department of Immunology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Masuet-Aumatell C; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Department of Preventive Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Rigo-Bonnin R; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Department of Clinical Laboratory, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Morandeira F; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Department of Immunology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Solanich X; Department of Internal Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.
Source: Frontiers in immunology [Front Immunol] 2022 Apr 29; Vol. 13, pp. 895209. Date of Electronic Publication: 2022 Apr 29 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35572562
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Antolí+A%22">Antolí A</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Rocamora-Blanch+G%22">Rocamora-Blanch G</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Framil+M%22">Framil M</searchLink>; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Department of Immunology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Mas-Bosch+V%22">Mas-Bosch V</searchLink>; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Department of Immunology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Navarro+S%22">Navarro S</searchLink>; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Department of Immunology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Bermudez+C%22">Bermudez C</searchLink>; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Martinez-Yelamos+S%22">Martinez-Yelamos S</searchLink>; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Department of Neurology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Dopico+E%22">Dopico E</searchLink>; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Deparment of Microbiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Calatayud+L%22">Calatayud L</searchLink>; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Deparment of Microbiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Garcia-Muñoz+N%22">Garcia-Muñoz N</searchLink>; Blood Bank Department - Banc de Sang i Teixits (BST), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Hernández-Benítez+LH%22">Hernández-Benítez LH</searchLink>; Blood Bank Department - Banc de Sang i Teixits (BST), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Riera-Mestre+A%22">Riera-Mestre A</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Bas+J%22">Bas J</searchLink>; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Department of Immunology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Masuet-Aumatell+C%22">Masuet-Aumatell C</searchLink>; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Department of Preventive Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Rigo-Bonnin+R%22">Rigo-Bonnin R</searchLink>; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Department of Clinical Laboratory, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Morandeira+F%22">Morandeira F</searchLink>; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Department of Immunology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Solanich+X%22">Solanich X</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2022 Apr 29; Vol. 13, pp. 895209. <i>Date of Electronic Publication: </i>2022 Apr 29 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35572562
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2022.895209
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 895209
    Titles:
      – TitleFull: Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Antolí A
      – PersonEntity:
          Name:
            NameFull: Rocamora-Blanch G
      – PersonEntity:
          Name:
            NameFull: Framil M
      – PersonEntity:
          Name:
            NameFull: Mas-Bosch V
      – PersonEntity:
          Name:
            NameFull: Navarro S
      – PersonEntity:
          Name:
            NameFull: Bermudez C
      – PersonEntity:
          Name:
            NameFull: Martinez-Yelamos S
      – PersonEntity:
          Name:
            NameFull: Dopico E
      – PersonEntity:
          Name:
            NameFull: Calatayud L
      – PersonEntity:
          Name:
            NameFull: Garcia-Muñoz N
      – PersonEntity:
          Name:
            NameFull: Hernández-Benítez LH
      – PersonEntity:
          Name:
            NameFull: Riera-Mestre A
      – PersonEntity:
          Name:
            NameFull: Bas J
      – PersonEntity:
          Name:
            NameFull: Masuet-Aumatell C
      – PersonEntity:
          Name:
            NameFull: Rigo-Bonnin R
      – PersonEntity:
          Name:
            NameFull: Morandeira F
      – PersonEntity:
          Name:
            NameFull: Solanich X
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 04
              Text: 2022 Apr 29
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1